Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Terns Pharmaceuticals Inc (NASDAQ: TERN) closed at $8.27 in the last session, up 0.85% from day before closing price of $8.20. In other words, the price has increased by $0.85 from its previous closing price. On the day, 0.93 million shares were traded. TERN stock price reached its highest trading level at $8.46 during the session, while it also had its lowest trading level at $8.07.
Ratios:
We take a closer look at TERN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.02 and its Current Ratio is at 21.02. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on June 22, 2023, initiated with a Buy rating and assigned the stock a target price of $16.
On June 07, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $18.
On May 31, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $23.ROTH MKM initiated its Buy rating on May 31, 2023, with a $23 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 12 ’24 when Lu Hongbo bought 476,190 shares for $10.50 per share. The transaction valued at 4,999,995 led to the insider holds 476,190 shares of the business.
Vignola Mark J. sold 10,000 shares of TERN for $110,000 on Sep 10 ’24. The Chief Financial Officer now owns 91,940 shares after completing the transaction at $11.00 per share. On Sep 09 ’24, another insider, Quigley Jill M., who serves as the Director of the company, sold 17,235 shares for $10.00 each. As a result, the insider received 172,350 and left with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 698285760 and an Enterprise Value of 356927712.
Stock Price History:
Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $3.26. The 50-Day Moving Average of the stock is 0.56%, while the 200-Day Moving Average is calculated to be 19.01%.
Shares Statistics:
According to the various share statistics, TERN traded on average about 1.91M shares per day over the past 3-months and 1257420 shares per day over the past 10 days. A total of 64.58M shares are outstanding, with a floating share count of 59.14M. Insiders hold about 29.95% of the company’s shares, while institutions hold 59.57% stake in the company. Shares short for TERN as of 1726185600 were 3763437 with a Short Ratio of 1.97, compared to 1723680000 on 1804399. Therefore, it implies a Short% of Shares Outstanding of 3763437 and a Short% of Float of 4.9000002.
Earnings Estimates
A comprehensive evaluation of Terns Pharmaceuticals Inc (TERN) is underway, with the input of 8.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.3 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$1.21 and -$1.41 for the fiscal current year, implying an average EPS of -$1.28. EPS for the following year is -$1.38, with 8.0 analysts recommending between -$1.01 and -$1.63.
